Epidemiology and Clinical Manifestations of Langerhans Cell Histiocytosis in Children

Chapter

Abstract

This chapter recounts the history of classification of LCH, the association with certain risk factors and with other malignancies, and the patterns of disease reported. In it, the history of LCH as a disease is told, from classification as three different diseases to unification as a single disease with a variable presentation. The chapter goes into further detail about the variety of different manifestations in different organ systems and assesses the evidence for suspected risk factors to LCH.

Keywords

History Letterer-Siwe Hand-Schüller-Christian Eosinophilic granuloma Risk factors Malignancy Pediatric 

References

  1. 1.
    Smith T. Skull cap showing congenital deficiency of bone. Trans Pathol Soc of Lond. 1865;16:224–5.Google Scholar
  2. 2.
    Hand A. Polyuria and tuberculosis. Arch Pediatr. 1893;10:673–5.Google Scholar
  3. 3.
    Kay TW. Acquired hydrocephalus with atrophic bone changes, exophthalmos, and polyuria (with presentation of the patient). Pa Med J. 1905;9:520–1.Google Scholar
  4. 4.
    Schüller A. Uber eigenartige schadeldefekte im jugendalter. Fortschritte Auf der Gebiete Rontgenstrahlen. 1915;23:12–8.Google Scholar
  5. 5.
    Christian HA. Defects in membranous bones, exophthalmos and diabetes insipidus; an unusual syndrome of dyspituitarism. Med Clin North Am. 1920;3:849–71.Google Scholar
  6. 6.
    Hand A. Defects of membranous bones, exophthalmos and polyuria in childhood: is it dyspituitarism? Am J Med Sci. 1921;162:509–15.CrossRefGoogle Scholar
  7. 7.
    Letterer E. Aleukämische Retikulose Ztschr f Path. 1924;30:377.Google Scholar
  8. 8.
    Siwe S. Die reticuloendotheliose - ein neues krankheitsbild unter den hepatosplenomegalien. Zeitschrift Fur Kinderheilkunde. 1933;55:212–47.CrossRefGoogle Scholar
  9. 9.
    Abt AF, Denenholz EJ. Letterer-Siwe’s disease; spleno-hepatomegaly, associated with widespread hyperplasia of non lipoid-storing macrophages; discussion of the so-called reticulo-endotheliosis. Am J Dis Child. 1936;51(3):499–522.CrossRefGoogle Scholar
  10. 10.
    Aschoff L. Das Reticulo-Endotheliale system. Ergebnisse Inner Medicin und Kinderheilkunde. 1924;26:1–117.Google Scholar
  11. 11.
    Finzi O. Mieloma con prevalenza delle cellule eosinofile, circoscritto all’ osso frontale in un giovane di 15 anni. Minerva Med. 1929;9(pt 1):239.Google Scholar
  12. 12.
    Mignon F. Ein granulationstumor des stirnbeins. Fortchritte RoÈntgenstrahlen. 1930;42:749–51.Google Scholar
  13. 13.
    Otani S, Erlich JC. Solitary granuloma of bone simulating primary neoplasm. Am J Pathol. 1940;16:479–90.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Lichtenstein L, Jaffe H. Eosinophilic granuloma of bone. Am J Path. 1940;16:595.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Wallgren A. Systemic reticulo-endothelial granuloma. Nonlipoid reticuloendotheliosis and Schüller-Christian disease. Am J Dis Child. 1940;60(3):471.CrossRefGoogle Scholar
  16. 16.
    Farber S. The nature of “solitary or eosinophilic granuloma” of bone. Am J Pathol. 1941;17:625–9.Google Scholar
  17. 17.
    Green WT, Farber S. “Eosinophilic or solitary Granuloma” of bone. J Bone Joint Surg. 1942;24:499–526.Google Scholar
  18. 18.
    Lichtenstein L. Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol. 1953;56(1):84–102.PubMedGoogle Scholar
  19. 19.
    Langerhans P. Ueber die Nerven der menschlichen llaut. Uber die Nerven der menslichen Haut Archive der Pathologischen Anatomie. 1868;44:325–37.Google Scholar
  20. 20.
    Nezelof C, Basset F, Rousseau MF. Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine. 1973;18(5):365–71.PubMedGoogle Scholar
  21. 21.
    Birbeck MS, Breathnach AS, Everall JD. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo**from the Chester Beatty research institute, Royal Cancer Hospital, London, S.W. 3, and the departments of anatomy, and dermatology, St. Mary’s Hospital medical school (University of London) London, W. 2, England. J Invest Dermatol. 1961;37(1):51–64.CrossRefGoogle Scholar
  22. 22.
    Risdall RJ, Dehner LP, Duray P, Kobrinsky N, Robison L, Nesbit ME Jr. Histiocytosis X (Langerhans’ cell histiocytosis). Prognostic role of histopathology. Arch Pathol Lab Med. 1983;107(2):59–63.PubMedGoogle Scholar
  23. 23.
    Chu T, D’Angio GJ, Favara B, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet. 1987;2:41–2.CrossRefPubMedGoogle Scholar
  24. 24.
    Alston RD, Tatevossian RG, McNally RJ, Kelsey A, Birch JM, Eden TO. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer. 2007;48(5):555–60.CrossRefPubMedGoogle Scholar
  25. 25.
    Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 2008;51(1):71–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Stalemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter JI. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51(1):76–81.CrossRefPubMedGoogle Scholar
  27. 27.
    Carstensen H, Ornvold K. The epidemiology of Langerhans cell histiocytosis in children in Denmark, 1975-89. Med Pediatr Oncol. 1993;21:385–8.CrossRefGoogle Scholar
  28. 28.
    Muller J, Garami M, Hauser P, Schuler D, Csoka M, Kovacs G, et al. Hungarian experience with Langerhans cell histiocytosis in childhood. Pediatr Hematol Oncol. 2006;23(2):135–42.CrossRefPubMedGoogle Scholar
  29. 29.
    German Childhood Cancer Registry. Annual Report 2015. Institute for Biostatistics, Epidemiology and Informatics.Google Scholar
  30. 30.
    Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn R, Windebank KP. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child. 2009;94(5):376–80.CrossRefPubMedGoogle Scholar
  31. 31.
    Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Respiratory failure research Group of J. Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med. 2001;40(10):998–1003.CrossRefPubMedGoogle Scholar
  32. 32.
    Bhatia S, Nesbit ME, Egeler RM, Buckley JD, Mertens A, Robison LL. Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr. 1997;130:774–84.CrossRefPubMedGoogle Scholar
  33. 33.
    Venkatramani R, Rosenberg S, Indramohan G, Jeng M, Jubran R. An exploratory epidemiological study of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012;59(7):1324–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Hamre M, Hedberg J, Buckley J, Bhatia S, Finlay J, Meadows A, et al. Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases. Med Pediatr Oncol. 1997;28:92–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Levendoglu-Tugal O, Noto R, Juster F, Brudnicki A, Slim M, Beneck D, et al. Langerhans cell histiocytosis associated with partial DiGeorge syndrome in a newborn. J Pediatr Hematol Oncol. 1996;18(4):401–4.CrossRefPubMedGoogle Scholar
  36. 36.
    Giordano P, Cecinati V, Grassi M, Giordani L, De Mattia D, Santoro N. Langerhans cell histiocytosis in a pediatric patient with thrombocytopenia-absent radius syndrome and 1q21.1 deletion: case report and proposal of a rapid molecular diagnosis of 1q21.1 deletion. Immunopharmacol Immunotoxicol. 2011;33(4):754–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Sheils C, Dover GJ. Frequency of congenital anomalies in patients with histiocytosis X. Am J Hematol. 1989;31(2):91–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Chen RL, Lin KS, Chang WH, Hsieh YL, Chen BW, Jaing TH, et al. Childhood Langerhans cell histiocytosis increased during el Nino 1997-98: a report from the Taiwan pediatric oncology group. Acta Paediatr Taiwan. 2003;44(1):14–20.PubMedGoogle Scholar
  39. 39.
    Egeler RM, Neglia JP, Arico M, Favara BE, Heitger A, Nesbit ME, et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-malignancy study Group of the Histiocyte Society. Hematol Oncol Clin North Am. 1998;12(2):369–78.CrossRefPubMedGoogle Scholar
  40. 40.
    Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71(3):865–73.CrossRefPubMedGoogle Scholar
  41. 41.
    Kallen B, Finnstrom O, Nygren KG, Olausson PO. In vitro fertilization in Sweden: child morbidity including cancer risk. Fertil Steril. 2005;84(3):605–10.CrossRefPubMedGoogle Scholar
  42. 42.
    Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics. 2010;126(2):270–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Aricoa M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, et al. Familial clustering of Langerhans cell histiocytosis. Br J Haematol. 1999;107:883–8.CrossRefGoogle Scholar
  44. 44.
    Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919–23.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211(4):669–83.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Haroche J, Charlotte F, Arnaud L, von Deimling A, Helias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700–3.CrossRefPubMedGoogle Scholar
  47. 47.
    Brown NA, Furtado LV, Betz BL, Kiel MJ, Weigelin HC, Lim MS, et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood. 2014;124(10):1655–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, et al. Langerhans’ cell histiocytosis (Histiocytosis X) - a clonal proliferative disease. N Engl J Med. 1994;331:154–60.CrossRefPubMedGoogle Scholar
  49. 49.
    Rodig SJ, Payne EG, Degar BA, Rollins B, Feldman AL, Jaffe ES, et al. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol. 2008;83(2):116–21.CrossRefPubMedGoogle Scholar
  50. 50.
    Michaloglou C, Vredeveld LC, Mooi WJ, Peeper DS. BRAF(E600) in benign and malignant human tumours. Oncogene. 2008;27(7):877–95.CrossRefPubMedGoogle Scholar
  51. 51.
    Ronceray L, Potschger U, Janka G, Gadner H, Minkov M, German Society for Pediatric H, et al. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. J Pediatr. 2012;161(1):129–33 e1-3.CrossRefPubMedGoogle Scholar
  52. 52.
    Simko SJ, Garmezy B, Abhyankar H, Lupo PJ, Chakraborty R, Lim KP, et al. Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr. 2014;165(5):990–6.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am. 1998;12(2):269–86.CrossRefPubMedGoogle Scholar
  54. 54.
    Ashena Z, Alavi S, Arzanian MT, Eshghi P. Nail involvement in langerhans cell histiocytosis. Pediatr Hematol Oncol. 2007;24(1):45–51.CrossRefPubMedGoogle Scholar
  55. 55.
    Battistella M, Fraitag S, Teillac DH, Brousse N, de Prost Y, Bodemer C. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms. Arch Dermatol. 2010;146(2):149–56.CrossRefPubMedGoogle Scholar
  56. 56.
    Slater JM, Swarm OJ. Eosinophilic granuloma of bone. Med Pediatr Oncol. 1980;8(2):151–64.CrossRefPubMedGoogle Scholar
  57. 57.
    Peng XS, Pan T, Chen LY, Huang G, Wang J. Langerhans’ cell histiocytosis of the spine in children with soft tissue extension and chemotherapy. Int Orthop. 2009;33(3):731–6.CrossRefPubMedGoogle Scholar
  58. 58.
    Grois N, Potschger U, Prosch H, Minkov M, Arico M, Braier J, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46(2):228–33.CrossRefPubMedGoogle Scholar
  59. 59.
    Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans’-cell histiocytosis. N Engl J Med. 2000;342(26):1969–78.CrossRefPubMedGoogle Scholar
  60. 60.
    Abbritti M, Mazzei MA, Bargagli E, Refini RM, Penza F, Perari MG, et al. Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis. Eur J Radiol. 2012;81(8):1907–12.CrossRefPubMedGoogle Scholar
  61. 61.
    Bernstrand C, Cederlund K, Henter JI. Pulmonary function testing and pulmonary Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;49(3):323–8.CrossRefPubMedGoogle Scholar
  62. 62.
    Ducassou S, Seyrig F, Thomas C, Lambilliotte A, Marec-Berard P, Berger C, et al. Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer. 2013;60(11):1759–65.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Madrigal-Martinez-Pereda C, Guerrero-Rodriguez V, Guisado-Moya B, Meniz-Garcia C. Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. Med Oral Patol Oral Cir Bucal. 2009;14(5):E222–8.PubMedGoogle Scholar
  64. 64.
    Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):287–305.CrossRefPubMedGoogle Scholar
  65. 65.
    Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, et al. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2004;43(5):594–9.CrossRefPubMedGoogle Scholar
  66. 66.
    Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol. 2004;25(5):880–91.PubMedGoogle Scholar
  67. 67.
    Di Iorgi N, Allegri AE, Napoli F, Calcagno A, Calandra E, Fratangeli N, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab. 2014;99(4):1264–72.CrossRefPubMedGoogle Scholar
  68. 68.
    Richards GE, Thomsett MJ, Boston BA, DiMeglio LA, Shulman DI, Draznin M. Natural history of idiopathic diabetes insipidus. J Pediatr. 2011;159(4):566–70.CrossRefPubMedGoogle Scholar
  69. 69.
    Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, et al. Central diabetes insipidus in children and young adults. N Engl J Med. 2000;343(14):998–1007.CrossRefPubMedGoogle Scholar
  70. 70.
    Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J, Writing C. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab. 2011;96(9):E1352–60.CrossRefPubMedGoogle Scholar
  71. 71.
    Dunger DB, Broadbent V, Yeoman E, Seckl JR, Lightman SL, Grant DB, et al. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N Engl J Med. 1989;321(17):1157–62.CrossRefPubMedGoogle Scholar
  72. 72.
    Donadieu J, Rolon MA, Thomas C, Brugieres L, Plantaz D, Emile JF, et al. Endocrine involvement in pediatric-onset Langerhans’ cell histiocytosis: a population-based study. J Pediatr. 2004;144(3):344–50.CrossRefPubMedGoogle Scholar
  73. 73.
    Fahrner B, Prosch H, Minkov M, Krischmann M, Gadner H, Prayer D, et al. Long-term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012;58(4):606–10.CrossRefPubMedGoogle Scholar
  74. 74.
    Wnorowski M, Prosch H, Prayer D, Janssen G, Gadner H, Grois N. Pattern and course of neurodegeneration in Langerhans cell histiocytosis. J Pediatr. 2008;153(1):127–32.CrossRefPubMedGoogle Scholar
  75. 75.
    Mittheisz E, Seidl R, Prayer D, Waldenmair M, Neophytou B, Potschger U, et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;48(1):50–6.CrossRefPubMedGoogle Scholar
  76. 76.
    McClain K, Ramsay NK, Robison L, Sundberg RD, Nesbit M Jr. Bone marrow involvement in histiocytosis X. Med Pediatr Oncol. 1983;11(3):167–71.CrossRefPubMedGoogle Scholar
  77. 77.
    Minkov M, Potschger U, Grois N, Gadner H, Dworzak MN. Bone marrow assessment in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;49(5):694–8.CrossRefPubMedGoogle Scholar
  78. 78.
    Galluzzo ML, Braier J, Rosenzweig SD, Garcia de Davila MT, Rosso D. Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis. Pediatr Dev Pathol. 2010;13(2):101–6.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Wong A, Ortiz-Neira CL, Reslan WA, Sharon R, Pinto-Rojas A, Kaura D, et al. Liver involvement in Langerhans cell histiocytosis. Pediatr Radiol. 2006;36(10):1105–7.CrossRefPubMedGoogle Scholar
  80. 80.
    Jaffe R. Liver involvement in the histiocytic disorders of childhood. Pediatr Dev Pathol. 2004;7(3):214–25.CrossRefPubMedGoogle Scholar
  81. 81.
    Braier J, Ciocca M, Latella A, de Davila MG, Drajer M, Imventarza O. Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis. Med Pediatr Oncol. 2002;38(3):178–82.CrossRefPubMedGoogle Scholar
  82. 82.
    Hadzic N, Pritchard J, Webb D, Portmann B, Heaton ND, Rela M, et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation. 2000;70(5):815–9.CrossRefPubMedGoogle Scholar
  83. 83.
    Geissmann F, Thomas C, Emile JF, Micheau M, Canioni D, Cerf-Bensussan N, et al. Digestive tract involvement in Langerhans cell histiocytosis. The French Langerhans cell Histiocytosis study group. J Pediatr. 1996;129(6):836–45.CrossRefPubMedGoogle Scholar
  84. 84.
    Hait E, Liang M, Degar B, Glickman J, Fox VL. Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Pediatrics. 2006;118(5):e1593–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S, et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans cell study group. Bone Marrow Transplant. 2003;31(12):1097–103.CrossRefPubMedGoogle Scholar
  86. 86.
    Burnett A, Carney D, Mukhopadhyay S, Scalzetti EM, Leino D, Souid AK. Thyroid involvement with Langerhans cell histiocytosis in a 3-year-old male. Pediatr Blood Cancer. 2008;50(3):726–7.CrossRefPubMedGoogle Scholar
  87. 87.
    Boztug K, Frimpong-Ansah K, Nanduri VR, Lawson J, Russell-Eggitt I, Brock P. Intraocular Langerhans cell histiocytosis in a neonate resulting in bilateral loss of vision. Pediatr Blood Cancer. 2006;47(5):633–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.The Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los AngelesLos AngelesUSA
  2. 2.Division of Haematology and Oncology, Department of PaediatricsThe Hospital for Sick Children, University of TorontoTorontoCanada

Personalised recommendations